Health
Genetically engineered intestinal organoids reveal potential treatment targets against SARS-CoV-2 – News-Medical.Net
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers…
Using CRISPR/Cas9 and human intestinal organoids to study genes implicated in the biology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), researchers from the Netherlands identified a specific serine protease (TMPRSS2) as an attractive pan-coronavirus therapeutic target. Their exciting findings are available in a study currently available on the bioRxiv* preprint server.
The current coronavirus disease (COVID-19) pandemic, caused by the SARS-CoV-2, has exposed earnest weaknesses…
-
Noosa News19 hours agoBob Katter threatens to punch Nine reporter during ant-immigration press conference
-
Business21 hours agoThis ASX 200 healthcare stock crashed 14% to 4-year low. Here’s what happened
-
Business18 hours agoDicker Data rides the AI trend to double digit growth
-
Business21 hours agoForget CBA shares, this ASX 200 financials stock could be a better buy